Priovant Therapeutics
Priovant Therapeutics Logo
About
Pipeline
Clinical Trials
News & Presentations
Careers
Contact
NEWS
7/25/2022
Behind Pfizer’s New Quest to Target a 'Transformation' in Pharma
6/28/2022
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
6/28/2022
Roivant Unveils Latest Spinout as Pfizer Entrusts JAK1/TYK2 to Priovant
6/28/2022
Pfizer, Roivant Unveil Priovant with High Potential TYK2/JAK1 Inhibitor
PRESENTATIONS
11/3/2022
Introduction to Priovant